StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by johnny007on Nov 16, 2021 5:31pm

194 Views

Post# 34133931

Back watching the massacre and ..

...bought a few shares around the CEO's option strike.
Not much, just for fun.

They have to pump this stock into EOY for a 1Q22 PP IMHO.

The silver lining today within the whole disastrous merger was
- Aristotles expanded to non cancer
- Using a little bit of Aristotles today

Not yet enough - versus - low SP.

We will see how this ends.

Have they locked up their new shares?

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"